AcelRx: Replacing Morphine With Department Of Defense Funding
February 15, 2017 at 11:08 AM EST
AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) is a micro-cap company focused on the development and commercialization of therapies for the ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.